Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 276 entries
Sorted by: Best Match Show Resources per page
Plasma Cell Gingivits-A Conflict of Diagnosis.

Journal of clinical and diagnostic research : JCDR

Prasanna JS, Mutyap DA, Pantula VR, Akula S, Chinthapalli B.
PMID: 28050510
J Clin Diagn Res. 2016 Nov;10(11):ZD01-ZD03. doi: 10.7860/JCDR/2016/21148.8763. Epub 2016 Nov 01.

Plasma Cell Gingivitis (PCG) is a rare condition of the gingiva which is benign in nature. In this condition there is enlargement of the marginal and attached gingiva. It is not only unaesthetic in appearance but also causes difficulty...

Cite
Prasanna JS, Mutyap DA, Pantula VR, et al. Plasma Cell Gingivits-A Conflict of Diagnosis. J Clin Diagn Res. 2016;10(11):ZD01-ZD03doi: 10.7860/JCDR/2016/21148.8763.
Prasanna, J. S., Mutyap, D. A., Pantula, V. R., Akula, S., & Chinthapalli, B. (2016). Plasma Cell Gingivits-A Conflict of Diagnosis. Journal of clinical and diagnostic research : JCDR, 10(11), ZD01-ZD03. https://doi.org/10.7860/JCDR/2016/21148.8763
Prasanna, Jammula Surya, et al. "Plasma Cell Gingivits-A Conflict of Diagnosis." Journal of clinical and diagnostic research : JCDR vol. 10,11 (2016): ZD01-ZD03. doi: https://doi.org/10.7860/JCDR/2016/21148.8763
Prasanna JS, Mutyap DA, Pantula VR, Akula S, Chinthapalli B. Plasma Cell Gingivits-A Conflict of Diagnosis. J Clin Diagn Res. 2016 Nov;10(11):ZD01-ZD03. doi: 10.7860/JCDR/2016/21148.8763. Epub 2016 Nov 01. PMID: 28050510; PMCID: PMC5198463.
Copy Download .nbib Format: NLM
Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients.

Pain research and treatment

Schifilliti C, Cucinotta L, Fedele V, Ingegnosi C, Luca S, Leotta C.
PMID: 24804094
Pain Res Treat. 2014;2014:849623. doi: 10.1155/2014/849623. Epub 2014 Apr 02.

The present study evaluated the effectiveness of micronized palmitoylethanolamide (PEA-m) treatment in reducing the painful symptoms experienced by diabetic patients with peripheral neuropathy. PEA-m, a fatty acid amide of the N-acylethanolamine family, was administered (300 mg twice daily) to...

Cite
Schifilliti C, Cucinotta L, Fedele V, et al. Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients. Pain Res Treat. 2014;2014:849623doi: 10.1155/2014/849623.
Schifilliti, C., Cucinotta, L., Fedele, V., Ingegnosi, C., Luca, S., & Leotta, C. (2014). Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients. Pain research and treatment, 2014849623. https://doi.org/10.1155/2014/849623
Schifilliti, Chiara, et al. "Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients." Pain research and treatment vol. 2014 (2014): 849623. doi: https://doi.org/10.1155/2014/849623
Schifilliti C, Cucinotta L, Fedele V, Ingegnosi C, Luca S, Leotta C. Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients. Pain Res Treat. 2014;2014:849623. doi: 10.1155/2014/849623. Epub 2014 Apr 02. PMID: 24804094; PMCID: PMC3996286.
Copy Download .nbib Format: NLM
Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy.

Cell journal

Lakkireddy S, Aula S, Avn S, Kapley A, Rao Digumarti R, Jamil K.
PMID: 26464823
Cell J. 2015;17(3):510-9. doi: 10.22074/cellj.2015.11. Epub 2015 Oct 07.

OBJECTIVE: Cytochrome P450 is one of the major drug metabolizing enzyme families and its role in metabolism of cancer drugs cannot be less emphasized. The association be- tween single nucleotide polymorphisms (SNPs) in CYP1A1 and pathogenesis of chronic myeloid...

Cite
Lakkireddy S, Aula S, Avn S, et al. Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy. Cell J. 2015;17(3):510-9doi: 10.22074/cellj.2015.11.
Lakkireddy, S., Aula, S., Avn, S., Kapley, A., Rao Digumarti, R., & Jamil, K. (2015). Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy. Cell journal, 17(3), 510-9. https://doi.org/10.22074/cellj.2015.11
Lakkireddy, Samyuktha, et al. "Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy." Cell journal vol. 17,3 (2015): 510-9. doi: https://doi.org/10.22074/cellj.2015.11
Lakkireddy S, Aula S, Avn S, Kapley A, Rao Digumarti R, Jamil K. Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy. Cell J. 2015;17(3):510-9. doi: 10.22074/cellj.2015.11. Epub 2015 Oct 07. PMID: 26464823; PMCID: PMC4601872.
Copy Download .nbib Format: NLM
Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks.

Clinical obesity

Rolland C, Lula S, Jenner C, Dyson L, Macdonald I, Johnston KL, Broom I.
PMID: 25586630
Clin Obes. 2013 Oct;3(5):150-7. doi: 10.1111/cob.12029. Epub 2013 Aug 23.

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Approximately 80% of people with type 2 diabetes mellitus (T2DM) are overweight or obese. Weight loss produces numerous benefits in T2DM. People with T2DM have difficulty losing and maintaining weight.WHAT THIS STUDY...

Cite
Rolland C, Lula S, Jenner C, et al. Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Clin Obes. 2013;3(5):150-7doi: 10.1111/cob.12029.
Rolland, C., Lula, S., Jenner, C., Dyson, L., Macdonald, I., Johnston, K. L., & Broom, I. (2013). Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Clinical obesity, 3(5), 150-7. https://doi.org/10.1111/cob.12029
Rolland, C, et al. "Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks." Clinical obesity vol. 3,5 (2013): 150-7. doi: https://doi.org/10.1111/cob.12029
Rolland C, Lula S, Jenner C, Dyson L, Macdonald I, Johnston KL, Broom I. Weight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Clin Obes. 2013 Oct;3(5):150-7. doi: 10.1111/cob.12029. Epub 2013 Aug 23. PMID: 25586630.
Copy Download .nbib Format: NLM
Potential Roles of Fungal Extracellular Vesicles during Infection.

mSphere

Joffe LS, Nimrichter L, Rodrigues ML, Del Poeta M.
PMID: 27390779
mSphere. 2016 Jun 29;1(4). doi: 10.1128/mSphere.00099-16. eCollection 2016.

Extracellular vesicles (EVs) are produced by virtually all cell types. Within the past few years, work in this field has revealed more information about fungal EVs. Fungal EVs have been shown to carry proteins, lipids, pigments, polysaccharides, and RNA;...

Cite
Joffe LS, Nimrichter L, Rodrigues ML, et al. Potential Roles of Fungal Extracellular Vesicles during Infection. mSphere. 2016;1(4)doi: 10.1128/mSphere.00099-16.
Joffe, L. S., Nimrichter, L., Rodrigues, M. L., & Del Poeta, M. (2016). Potential Roles of Fungal Extracellular Vesicles during Infection. mSphere, 1(4), . https://doi.org/10.1128/mSphere.00099-16
Joffe, Luna S, et al. "Potential Roles of Fungal Extracellular Vesicles during Infection." mSphere vol. 1,4 (2016). doi: https://doi.org/10.1128/mSphere.00099-16
Joffe LS, Nimrichter L, Rodrigues ML, Del Poeta M. Potential Roles of Fungal Extracellular Vesicles during Infection. mSphere. 2016 Jun 29;1(4). doi: 10.1128/mSphere.00099-16. eCollection 2016. PMID: 27390779; PMCID: PMC4933989.
Copy Download .nbib Format: NLM
Evaluation of Neurodevelopment and Factors Affecting it in Children With Acyanotic Congenital Cardiac Disease.

Iranian journal of pediatrics

Ozmen A, Terlemez S, Tunaoglu FS, Soysal S, Pektas A, Cilsal E, Koca U, Kula S, Deniz Oguz A.
PMID: 26848374
Iran J Pediatr. 2016 Feb;26(1):e3278. doi: 10.5812/ijp.3278. Epub 2016 Jan 30.

BACKGROUND: The rate of congenital heart disease is 0.8% in all live births. The majority of this, however, is acyanotic congenital heart disease. The survival rate of children with cardiac disease has increased with the developments provided in recent...

Cite
Ozmen A, Terlemez S, Tunaoglu FS, et al. Evaluation of Neurodevelopment and Factors Affecting it in Children With Acyanotic Congenital Cardiac Disease. Iran J Pediatr. 2016;26(1):e3278doi: 10.5812/ijp.3278.
Ozmen, A., Terlemez, S., Tunaoglu, F. S., Soysal, S., Pektas, A., Cilsal, E., Koca, U., Kula, S., & Deniz Oguz, A. (2016). Evaluation of Neurodevelopment and Factors Affecting it in Children With Acyanotic Congenital Cardiac Disease. Iranian journal of pediatrics, 26(1), e3278. https://doi.org/10.5812/ijp.3278
Ozmen, Ayten, et al. "Evaluation of Neurodevelopment and Factors Affecting it in Children With Acyanotic Congenital Cardiac Disease." Iranian journal of pediatrics vol. 26,1 (2016): e3278. doi: https://doi.org/10.5812/ijp.3278
Ozmen A, Terlemez S, Tunaoglu FS, Soysal S, Pektas A, Cilsal E, Koca U, Kula S, Deniz Oguz A. Evaluation of Neurodevelopment and Factors Affecting it in Children With Acyanotic Congenital Cardiac Disease. Iran J Pediatr. 2016 Feb;26(1):e3278. doi: 10.5812/ijp.3278. Epub 2016 Jan 30. PMID: 26848374; PMCID: PMC4733290.
Copy Download .nbib Format: NLM
The build-up of clinical science.

Journal of nephrology

De Santo NG, Bisaccia C, De Santo LS, Cirillo M, Richet G.
PMID: 16874709
J Nephrol. 2006 May-Jun;19:S14-21.

In the years 1720-1820 medicine changed from an art into a science. The slow construction of clinical science, a process still to be completed, has many founding fathers. Here the transition is analyzed through the biographic studies of John...

Cite
De Santo NG, Bisaccia C, De Santo LS, et al. The build-up of clinical science. J Nephrol. 2006;19:S14-21
De Santo, N. G., Bisaccia, C., De Santo, L. S., Cirillo, M., & Richet, G. (2006). The build-up of clinical science. Journal of nephrology, 19S14-21.
De Santo, Natale G, et al. "The build-up of clinical science." Journal of nephrology vol. 19 (2006): S14-21.
De Santo NG, Bisaccia C, De Santo LS, Cirillo M, Richet G. The build-up of clinical science. J Nephrol. 2006 May-Jun;19:S14-21. PMID: 16874709.
Copy Download .nbib Format: NLM
The incidence of caesarean sections in the university clinical center of kosovo.

Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH

Elshani B, Daci A, Gashi S, Lulaj S.
PMID: 23378692
Acta Inform Med. 2012 Dec;20(4):244-8. doi: 10.5455/aim.2012.20.244-248.

INTRODUCTION: As in most countries of the world also at Kosovo the rate of Cesarean section from year to year is increasing.AIM: The main purpose of this paper was to present the incidence of births completed by Caesarean section...

Cite
Elshani B, Daci A, Gashi S, et al. The incidence of caesarean sections in the university clinical center of kosovo. Acta Inform Med. 2012;20(4):244-8doi: 10.5455/aim.2012.20.244-248.
Elshani, B., Daci, A., Gashi, S., & Lulaj, S. (2012). The incidence of caesarean sections in the university clinical center of kosovo. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 20(4), 244-8. https://doi.org/10.5455/aim.2012.20.244-248
Elshani, Brikene, et al. "The incidence of caesarean sections in the university clinical center of kosovo." Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH vol. 20,4 (2012): 244-8. doi: https://doi.org/10.5455/aim.2012.20.244-248
Elshani B, Daci A, Gashi S, Lulaj S. The incidence of caesarean sections in the university clinical center of kosovo. Acta Inform Med. 2012 Dec;20(4):244-8. doi: 10.5455/aim.2012.20.244-248. PMID: 23378692; PMCID: PMC3558290.
Copy Download .nbib Format: NLM
Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Fung LS, Klockau C.
PMID: 22477802
J Pediatr Pharmacol Ther. 2010 Apr;15(2):119-25.

OBJECTIVE: The objective of this dose range study is to expand on the relationship between age and weight-based doses of enoxaparin and resulting levels of anti-factor Xa (anti-Xa) in pediatric patients. The primary outcome of this study is to...

Cite
Fung LS, Klockau C. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients. J Pediatr Pharmacol Ther. 2010;15(2):119-25
Fung, L. S., & Klockau, C. (2010). Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 15(2), 119-25.
Fung, Lela S, and Klockau, Christopher. "Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 15,2 (2010): 119-25.
Fung LS, Klockau C. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients. J Pediatr Pharmacol Ther. 2010 Apr;15(2):119-25. PMID: 22477802; PMCID: PMC3018183.
Copy Download .nbib Format: NLM
Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Fung LS, Klockau C.
PMID: 22477802
J Pediatr Pharmacol Ther. 2010 Apr;15(2):119-25.

OBJECTIVE: The objective of this dose range study is to expand on the relationship between age and weight-based doses of enoxaparin and resulting levels of anti-factor Xa (anti-Xa) in pediatric patients. The primary outcome of this study is to...

Cite
Fung LS, Klockau C. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients. J Pediatr Pharmacol Ther. 2010;15(2):119-25
Fung, L. S., & Klockau, C. (2010). Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 15(2), 119-25.
Fung, Lela S, and Klockau, Christopher. "Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 15,2 (2010): 119-25.
Fung LS, Klockau C. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients. J Pediatr Pharmacol Ther. 2010 Apr;15(2):119-25. PMID: 22477802; PMCID: PMC3018183.
Copy Download .nbib Format: NLM
A decision tree model for the prediction of homodimer folding mechanism.

Bioinformation

Suresh A, Karthikraja V, Lulu S, Kangueane U, Kangueane P.
PMID: 20461159
Bioinformation. 2009 Nov 17;4(5):197-205. doi: 10.6026/97320630004197.

The formation of protein homodimer complexes for molecular catalysis and regulation is fascinating. The homodimer formation through 2S (2 state), 3SMI (3 state with monomer intermediate) and 3SDI (3 state with dimer intermediate) folding mechanism is known for 47...

Cite
Suresh A, Karthikraja V, Lulu S, et al. A decision tree model for the prediction of homodimer folding mechanism. Bioinformation. 2009;4(5):197-205doi: 10.6026/97320630004197.
Suresh, A., Karthikraja, V., Lulu, S., Kangueane, U., & Kangueane, P. (2009). A decision tree model for the prediction of homodimer folding mechanism. Bioinformation, 4(5), 197-205. https://doi.org/10.6026/97320630004197
Suresh, Abishek, et al. "A decision tree model for the prediction of homodimer folding mechanism." Bioinformation vol. 4,5 (2009): 197-205. doi: https://doi.org/10.6026/97320630004197
Suresh A, Karthikraja V, Lulu S, Kangueane U, Kangueane P. A decision tree model for the prediction of homodimer folding mechanism. Bioinformation. 2009 Nov 17;4(5):197-205. doi: 10.6026/97320630004197. PMID: 20461159; PMCID: PMC2859576.
Copy Download .nbib Format: NLM
Biogenesis of extracellular vesicles in yeast: Many questions with few answers.

Communicative & integrative biology

Oliveira DL, Nakayasu ES, Joffe LS, Guimarães AJ, Sobreira TJ, Nosanchuk JD, Cordero RJ, Frases S, Casadevall A, Almeida IC, Nimrichter L, Rodrigues ML.
PMID: 21331232
Commun Integr Biol. 2010 Nov;3(6):533-5. doi: 10.4161/cib.3.6.12756. Epub 2010 Nov 01.

The cellular events required for unconventional protein secretion in eukaryotic pathogens are beginning to be revealed. In fungi, extracellular release of proteins involves passage through the cell wall by mechanisms that are poorly understood. In recent years, several studies...

Cite
Oliveira DL, Nakayasu ES, Joffe LS, et al. Biogenesis of extracellular vesicles in yeast: Many questions with few answers. Commun Integr Biol. 2010;3(6):533-5doi: 10.4161/cib.3.6.12756.
Oliveira, D. L., Nakayasu, E. S., Joffe, L. S., Guimarães, A. J., Sobreira, T. J., Nosanchuk, J. D., Cordero, R. J., Frases, S., Casadevall, A., Almeida, I. C., Nimrichter, L., & Rodrigues, M. L. (2010). Biogenesis of extracellular vesicles in yeast: Many questions with few answers. Communicative & integrative biology, 3(6), 533-5. https://doi.org/10.4161/cib.3.6.12756
Oliveira, Débora L, et al. "Biogenesis of extracellular vesicles in yeast: Many questions with few answers." Communicative & integrative biology vol. 3,6 (2010): 533-5. doi: https://doi.org/10.4161/cib.3.6.12756
Oliveira DL, Nakayasu ES, Joffe LS, Guimarães AJ, Sobreira TJ, Nosanchuk JD, Cordero RJ, Frases S, Casadevall A, Almeida IC, Nimrichter L, Rodrigues ML. Biogenesis of extracellular vesicles in yeast: Many questions with few answers. Commun Integr Biol. 2010 Nov;3(6):533-5. doi: 10.4161/cib.3.6.12756. Epub 2010 Nov 01. PMID: 21331232; PMCID: PMC3038056.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 276 entries